Linagliptin Parent Nucleus Intermediate CAS 853029-57-9 Kemurnian ≥99.0% Gambar Unggulan Pabrik

Linagliptin Parent Nucleus Intermediate CAS 853029-57-9 Kemurnian ≥99.0% Pabrik

Katrangan singkat:

Jeneng: Linagliptin Parent Nucleus Intermediate

CAS: 853029-57-9

Kemurnian: ≥99,0%

Penampilan: Bubuk putih nganti kuning cahya

Intermediate kanggo Linagliptin (CAS: 668270-12-0) kanggo perawatan diabetes mellitus jinis II

Kualitas Tinggi, Produksi Komersial

E-Mail: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Produsen Pasokan Linagliptin lan Intermediet sing Gegandhengan:
Linagliptin CAS 668270-12-0
Linagliptin Induk Nukleus Penengah CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Sifat Kimia:

Jeneng Kimia	8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
sinonim	Nukleus Induk Linagliptin;Linagliptin Intermediate F
Nomer CAS	853029-57-9
Nomer CAT	RF-PI502
Status Simpenan	Ing Simpenan, Skala Produksi Nganti Ton
Formula Molekul	C20H17BrN6O2
Bobot Molekul	453.29
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Bubuk putih nganti kuning cahya
Identifikasi	IR/HPLC
Kemurnian	≥99,0%
Banyu (KF)	≤1,0%
Sisa ing Ignition	≤0,50%
Total Impurities	≤1,0%
Standar Tes	Standar Perusahaan
Panggunaan	Intermediate kanggo Linagliptin (CAS: 668270-12-0)

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, 25kg / Drum Karton, utawa miturut kabutuhan pelanggan.

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan.

Kaluwihan:

FAQ:

Aplikasi:

8-Bromo-7-nanging-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (CAS: 853029-57- 9) minangka inti induk saka Linagliptin (CAS: 668270-12-0).Linagliptin (jeneng dagang Tradjenta lan Trajetna) minangka inhibitor dipeptidyl peptidase-4 (DPP-4) sing disetujoni dening FDA AS ing Mei 2011 kanggo perawatan diabetes Tipe 2 bebarengan karo diet lan olahraga.Linagliptin (BI-1356) diterangake minangka inhibitor DPP-4 sing selektif banget, alon-alon lan tumindak dawa.Linagliptin muncul saka upaya optimalisasi inhibitor DPP-4 berbasis xanthine kanthi timbal awal sing diidentifikasi saka kampanye HTS.